Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Biotechnology industry leader Centocor Ortho Biotech is now Janssen Biotech, Inc., part of the Janssen pharmaceutical companies
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
Translating Fatigue to Human Performance.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis.
Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Mast cells: an expanding pathophysiological role from allergy to other disorders.
Isolated trigeminal nerve palsy with motor involvement as a presenting manifestation of multiple sclerosis in an equatorial region - a case report.
Targeting IRF4 in autoimmune diseases.
CCSVI and MS: no meaning, no fact.
Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
Individual variability in speed of information processing: An index of cognitive impairment in multiple sclerosis.
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
Laquinimod Halted MS Disability But Not Relapses
Periventricular Demyelination and Axonal Pathology Is Associated with Subependymal Virus Spread in a Murine Model for Multiple Sclerosis.
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.
Pages
« first
‹ previous
…
169
170
171
172
173
174
175
176
177
…
next ›
last »